authors
- Fu, S
- Hirte, Holger
- Welch, S
- Ilenchuk, TT
- Lutes, T
- Rice, C
- Fields, N
- Nemet, A
- Dugourd, D
- Piha-Paul, S
- Subbiah, V
- Liu, L
- Gong, J
- Hong, Dennis
- Stewart, JM
Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 2017
has subject area
- 1115 Pharmacology and Pharmaceutical Sciences (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Investigational New Drugs Journal